| Primary |
| Depression |
50.0% |
| Meningitis Enterococcal |
50.0% |
|
| Serotonin Syndrome |
100.0% |
|
| Secondary |
| Epilepsy |
38.4% |
| Drug Use For Unknown Indication |
15.4% |
| Product Used For Unknown Indication |
12.8% |
| Drug Exposure During Pregnancy |
4.0% |
| Convulsion |
3.1% |
| Sedation |
3.0% |
| Status Epilepticus |
2.9% |
| Anxiety |
2.5% |
| Hypertension |
2.4% |
| Partial Seizures |
2.1% |
| Prophylaxis |
1.9% |
| Intentional Overdose |
1.9% |
| Poisoning Deliberate |
1.6% |
| Maternal Exposure Timing Unspecified |
1.2% |
| Metastatic Malignant Melanoma |
1.2% |
| Small Cell Lung Cancer Stage Unspecified |
1.2% |
| Tuberculosis |
1.2% |
| Escherichia Infection |
1.1% |
| Optic Neuropathy |
1.1% |
| Sjogren's Syndrome |
1.1% |
|
| Thrombocytopenia |
18.9% |
| Premature Baby |
12.3% |
| Retrognathia |
7.5% |
| Somnolence |
5.7% |
| Septic Shock |
4.7% |
| Condition Aggravated |
3.8% |
| Drug Exposure During Pregnancy |
3.8% |
| Neutropenia |
3.8% |
| Nystagmus |
3.8% |
| Pneumomediastinum |
3.8% |
| Premature Rupture Of Membranes |
3.8% |
| Respiratory Distress |
3.8% |
| Vomiting |
3.8% |
| Weight Decreased |
3.8% |
| Congenital Teratoma |
2.8% |
| Electrocardiogram Qt Prolonged |
2.8% |
| Eosinophilia |
2.8% |
| Epilepsy |
2.8% |
| Fall |
2.8% |
| General Physical Health Deterioration |
2.8% |
|
| Concomitant |
| Epilepsy |
34.9% |
| Product Used For Unknown Indication |
22.5% |
| Drug Use For Unknown Indication |
11.5% |
| Depression |
3.6% |
| Anxiety |
3.1% |
| Hypertension |
2.9% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Partial Seizures |
2.4% |
| Unevaluable Event |
2.1% |
| Convulsion |
1.9% |
| Multiple Sclerosis |
1.8% |
| Hiv Infection |
1.7% |
| Convulsion Prophylaxis |
1.6% |
| Pain |
1.4% |
| Anxiolytic Therapy |
1.2% |
| Metastases To Central Nervous System |
1.1% |
| Optic Neuropathy |
1.1% |
| Diabetes Mellitus |
0.9% |
| Prophylaxis |
0.9% |
| Temporal Lobe Epilepsy |
0.9% |
|
| Thrombocytopenia |
16.3% |
| Epilepsy |
9.4% |
| Vomiting |
8.9% |
| Convulsion |
6.4% |
| Neutropenia |
5.9% |
| Tremor |
5.4% |
| Weight Decreased |
5.4% |
| Rash |
4.9% |
| Somnolence |
4.4% |
| Platelet Count Decreased |
3.9% |
| Pyrexia |
3.9% |
| Status Epilepticus |
3.9% |
| Weight Increased |
3.9% |
| Cerebellar Syndrome |
3.0% |
| Delirium |
2.5% |
| Pregnancy |
2.5% |
| Skin Exfoliation |
2.5% |
| Toxic Skin Eruption |
2.5% |
| Urinary Tract Infection |
2.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.0% |
| Partial Seizures |
20.0% |
| Epilepsy |
16.7% |
| Anxiety |
6.7% |
| Device Related Infection |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Sleep Disorder |
6.7% |
| Smoking Cessation Therapy |
6.7% |
| Cachexia |
3.3% |
| Contraception |
3.3% |
| Eczema |
3.3% |
|
| Drug Interaction |
16.7% |
| Fall |
16.7% |
| Hypothermia |
16.7% |
| Nervousness |
16.7% |
| Wrong Drug Administered |
16.7% |
| Dizziness |
8.3% |
| Laceration |
8.3% |
|
